Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

BIIBBIIB
Showing 5 of 16 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in BIOGEN INC

No. Jacobs Levy Equity Management exited its BIIB (Biogen) position in Q1 2026. Its Q4 2025 13F listed 9,873 shares worth $1.7M. Jacobs Levy Equity Management first reported BIIB in Q2 2019 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$8.4M

Total Shares Change

-61,393

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$183.33
0
2025-Q4
Decreased
9,873
-2.5%
$1.7M0.0%$175.99
0
2025-Q3
Decreased
10,124
-19.8%
$1.4M0.0%$140.08
0
2025-Q2
Decreased
12,625
-79.4%
$1.6M0.0%$125.59
0
2025-Q1
New
61,393
-
$8.4M0.0%$136.84
38

Other major holders of BIIB: BNP PARIBAS FINANCIAL MARKETS, PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used